Good Governance for Medicines Programme Phase I: National assessment
The objective of the national assessment is to provide countries with a comprehensive picture of the level of transparency and potential vulnerability to corruption of the following eight functions of the pharmaceutical sector:
- registration of medicines,
- control of medicine promotion,
- inspection of establishments,
- Control of clinical trials,
- Licensing of establishments,
- selection of essential medicines,
- procurement of medicines,
- distribution of medicines
The assessment is an essential step in developing a national programme promoting good governance in the public pharmaceutical sector and revising related administrative procedures through a national consultation process.
The transparency assessment is not an end in itself, but rather the beginning of a process aimed at bringing long-lasting changes through efforts to promote good governance practices among health professionals in the public pharmaceutical sector.
The implementation of assessment's recommendations will build a more transparent and accountable pharmaceutical sector in the participating countries, improving equitable access to good-quality and safe medicines.
The methodology provides both qualitative and quantitative information on the level of transparency present in the eight areas. It collects qualitative information on structural indicators and quantification is then used to define the level of transparency for each function.